Healthcare // Animal Health
The global veterinary pain management market
is foreseen to grow by 6.6%, from USD 1.98 Billion in 2022 to USD 3.30 Billion in
2030. Growth in companion animal population, increasing consumption of meat
& milk, growing prevalence of diseases is to drive the market for the
upcoming forecast period. However, rising pet care costs, side effects
associated with treatment and high cost of certain products remains one factor
hindering the market growth over the anticipated period.
Market Definition
What Is Veterinary Pain Management?
Market Overview
Veterinary pain management aims to alleviate
pain and discomfort in animals caused by various conditions, including
injuries, surgeries, chronic illnesses, and age-related ailments. Pain can
significantly affect an animal's quality of life, leading to behavioral
changes, reduced mobility, and compromised overall health. By effectively
managing pain, veterinarians not only relieve suffering but also promote faster
recovery, improve outcomes, and enhance the animal's overall well-being.
Animal Welfare Awareness: The growing
awareness and understanding of animal welfare have led to increased demand for
comprehensive pain management in veterinary practice. Pet owners are now more
educated about the importance of identifying and treating pain in their
animals, prompting veterinarians to prioritize pain assessment and employ
appropriate pain management techniques.
Advancements in Pain Assessment:
Technological advancements in veterinary medicine have facilitated better pain
assessment in animals. Tools such as pain scales, diagnostic imaging, and
biomarkers help veterinarians accurately evaluate pain intensity, duration, and
its impact on the animal's physiological and behavioral well-being. This
enables tailored pain management plans and ensures optimal care for individual
animals.
Multimodal Pain Management Approaches:
Veterinary medicine has embraced the concept of multimodal pain management,
which involves combining various techniques and medications to achieve
synergistic pain relief. These approaches may include pharmacological
interventions, physical therapies, acupuncture, rehabilitation exercises, and
complementary therapies. By employing a multimodal approach, veterinarians can
address pain from different angles, enhancing its efficacy and minimizing
potential side effects.
Government Policies and Animal Welfare
Regulatory Guidelines: Governments play a
crucial role in promoting veterinary pain management through the establishment
of regulatory guidelines. These guidelines outline the standards of care for
pain management in animals, ensuring that veterinarians follow best practices
to alleviate pain effectively. Governments often collaborate with professional
veterinary organizations to develop evidence-based guidelines and provide
training and resources to veterinary professionals.
Animal Welfare Legislation: Government
policies focused on animal welfare prioritize the prevention and management of
pain in animals. Animal welfare acts and regulations mandate that animals be
protected from unnecessary suffering and pain. These policies may encompass
specific provisions for pain management during procedures, surgeries, and other
veterinary interventions. Compliance with these regulations is essential for
veterinarians and animal care facilities to uphold ethical practices and
provide the best possible care to animals.
Research Funding and Education: Governments
often allocate research funding to support studies on veterinary pain
management. This funding enables the development of new pain management
techniques, medications, and treatment modalities specific to animals.
Additionally, governments invest in educational initiatives to train veterinary
professionals in pain assessment and management, ensuring the availability of
competent and compassionate practitioners in the field.
DRIVERS in Veterinary Pain Management Market
Surge in the number of veterinary
practitioners in developed economies
The increasing presence of veterinary
professionals in developed nations is a key catalyst for the growth of private
clinical practices and hospitals. According to the American Veterinary Medical
Association, the veterinary workforce in the United States has witnessed a rise
from 117,735 in 2017 to 124,069 in 2023. Similarly, countries like Australia
and New Zealand are experiencing a yearly growth rate of over 3-4% in their
veterinarian count. This trend is expected to fuel the demand for veterinary
pain management products during the forecast period. The market's growth is
driven by the higher incidence of painful and inflammatory conditions in
animals, the need for accessible and cost-effective treatment options, and the
growing awareness regarding animal health and welfare. For example, a study by
the Morris Animal Foundation in March 2021 revealed that osteoarthritis affects
approximately 14.0 million adult dogs annually in the United States, making it
a top concern for pet owners. Additionally, the American Animal Health
Association reported in April 2021 that around 6.0 million dogs are diagnosed
with cancer each year, with approximately one in four dogs developing cancer at
some point, especially those older than ten.
Government and organizational initiatives are
also expected to contribute positively to the market's growth. The Federation
of European Companion Animal Veterinary Associations (FECAVA) launched the
"FECAVA Basic Practices in Anesthesia and Analgesia" campaign, which
involves essential lectures across Europe in the coming years and a series of
printable posters and infographics related to animal anesthesia and pain
management. Such supportive endeavors are anticipated to create new
opportunities for the market in the future.
RESTRAINTS in Veterinary Pain Management
Market
Several pain management drugs used in
veterinary medicine are exclusively available through prescriptions,
necessitating their administration by licensed veterinarians. This regulatory
restriction ensures appropriate usage, preventing the misuse or overuse of
controlled substances. Veterinary practices and practitioners are subject to
oversight by regulatory bodies that establish guidelines, standards, and
licensing requirements. These governing bodies often enforce specific
regulations related to pain management practices and medication usage. Certain
pain medications fall into the category of controlled substances, which are
subjected to additional regulations to prevent their improper use. These
substances may require specialized storage, meticulous record-keeping, and
periodic inspections. Veterinarians must adhere to animal welfare regulations
when addressing pain management in animals. These regulations encompass
guidelines on the proper use of pain medications, treatment protocols, and the
significance of monitoring and assessing pain levels in animals. Veterinary
professionals, including veterinarians and technicians, must obtain appropriate
licenses to practice and may be required to fulfill continuing education
requirements to stay updated with the latest advancements in pain management
techniques and medications.
OPPORTUNITIES in Veterinary Pain Management
Market
Rising acceptance of alternative and non-drug
treatment methods
The increasing acceptance of
non-pharmaceutical techniques for managing pain presents significant
opportunities for the market's future growth. Non-conventional approaches such
as laser therapy and electromagnetic therapy are gaining popularity as they
offer advantages over traditional pharmaceutical pain management options. Laser
therapy involves using light energy of specific wavelength, frequency, and
power to alleviate inflammation and pain, while electromagnetic therapy
utilizes magnetic fields, radio waves, and other forms of electromagnetic
energy at desired intensities. These therapies address the root causes of pain,
eliminating the need for invasive surgeries and reducing reliance on pain
relief drugs. Moreover, they contribute to shorter healing periods for
patients.
Key players like K-Laser USA and Assisi are
actively involved in developing devices for laser and electromagnetic therapy,
respectively. Assisi, for example, promotes its FDA-approved non-pharmaceutical
anti-inflammatory device (tPEMF therapy) as a solution that accelerates wound
healing by up to 58%. These companies continue to innovate and introduce new
pain management devices. K-Laser USA, for instance, has developed Platinum 4,
the world's first smart laser equipped with advanced features such as tailored
power, wavelength, pulsing, and expert protocols. The device is supported by a
performance tracking app that provides treatment statistics, revenue generation
calculations, and comprehensive patient profiles.
CHALLENGES in Veterinary Pain Management
Market
Rigorous regulatory procedures
Strict regulations surround veterinary pain
management products to ensure animal health, quality, and efficacy. Regulatory
bodies, including the Veterinary International Committee for Harmonization
(VICH), collaborate with authorities in the US, Europe, and Japan to establish
guidelines. Regulatory agencies such as the US FDA, Canadian Food Agency,
European Medicines Agency, Ministry of Agriculture, Forestry, and Fisheries
(MAFF), and the Australian Pesticides and Veterinary Medicines Authority
(APVMA) play crucial roles in approving veterinary medicines, overseeing the
regulatory Route Of Administration, and maintaining product safety standards.
Last year, the drug market witnessed
significant revenue growth, primarily driven by the increased utilization of
NSAIDs for animal treatment. Among the drug market segment, NSAIDs emerged as
the dominant sub-segment due to their widespread use in managing pain and
inflammation associated with osteoarthritis. To minimize side effects and
improve efficacy, companies are actively developing new NSAIDs.
In contrast, the forecast period anticipates
a gradual increase in opioids due to stringent regulations. The FDA has imposed
strict guidelines governing the manufacturing, storage, and sale of opioid
medications to prevent their misuse by pet owners. These regulations are
expected to limit the growth of the opioids segment in the coming years.
The veterinary pain management market is
categorized into various applications, including joint pain, post-operative
pain, cancer, and others. The post-operative segment held the second largest
market share last year, driven by the rising number of veterinary surgeries in
both developed and developing markets.
Regarding animal types, companion animals and
livestock animals are the key segments of the veterinary pain management
market. Among companion animals, cats accounted for the largest market share
last year. This can be attributed to the increasing ownership of cats and the
growing expenditure on pet healthcare. On the other hand, the livestock animal
segment is expected to have a significant market share due to the rising
prevalence of chronic diseases, increased awareness among animal healthcare
organizations, and higher spending on animal healthcare in developing
countries.
Livestock animals often exhibit visual signs
of discomfort, including lameness, accelerated breathing, increased
vocalization, expiratory grunts, and teeth grinding. The most commonly
prescribed treatments for livestock animals include NSAIDs, adrenergic
medications, and local anesthetics.
Furthermore, the companion animal category is
projected to witness steady growth throughout the forecast period, driven by
increasing ownership, awareness, and the demand for effective animal care. The
rising prevalence of obesity and chronic diseases like osteoarthritis and
cancer among companion animals further fuels market growth.
In terms of end users, veterinary hospitals
accounted for the largest share of the veterinary pain management market during
the forecast period. This can be attributed to the large pool of veterinarians,
the establishment of private hospitals by veterinarians, increased visits by
animal owners, and the growing adoption of pet healthcare insurance. Veterinary
clinics and pharmacies & drug stores are also significant contributors to
the market but to a lesser extent compared to veterinary hospitals.
Laser therapy is a widely utilized treatment
for various conditions such as chronic and acute injuries, arthritis, sprains
and strains, swelling caused by back disc problems, and muscular-skeletal
abnormalities. Additionally, it has proven effective in promoting nerve tissue
regeneration following surgical procedures. Among the most commonly performed
laser therapies in the veterinary field is the treatment of osteoarthritis (OA)
in dogs and cats. The recommended laser intensity for OA typically ranges
between 8 and 10 J/cm2. Laser therapy can also be beneficial for tendonitis due
to its ability to reduce inflammation associated with the condition.
Certain laser devices offer versatility for
both surgical and therapeutic applications through emission level control.
Notable brands specializing in laser therapy for veterinary pain management
include B-Cure Laser, TENDLITE, Lumasoothe, iReliev, Keebomed, and MLS Laser
Therapy (ASAveterinary), among others. These brands provide reliable options
for veterinary professionals seeking effective laser therapy solutions.
Market Segmentation
For the purpose of this report, the global Veterinary
Pain Management market segmented on the basis of product type, application, route
of administration, animal type, end user, and region:
Product Type Outlook:
On the basis of Product Type, the market is
segmented into Drug Type, Device Type. Further, Drug Type is segmented into
NSAIDs, Opioids, Local Anesthetics, Alpha-2 Agonists, Disease-modifying
Osteoarthritis Agents, Others. Further, Device Type is segmented into Laser
Therepy Device, Electromagnetic Device.
Application Outlook:
On the basis of application, the market is
segmented into postoperative, cancer, arthritis, others.
Route Of Administration Outlook:
On the basis of route of administration, the
market is segmented into oral, parenteral, topical.
Figure 1 Veterinary Pain Management Market By Route Of Administration (Market Size And Forecast By Value - USD Million, 2022 & 2030)
End User Outlook:
On the basis of end user, the market is
segmented into veterinary hospitals, veterinary clinics, pharmacies and drug
store.
Animal Type Outlook:
On the basis of animal type, the market is
segmented into companion animal, livestock animal.
Regional Outlook (Revenue, USD Million; 2022 & 2030)
Regional Outlook (Revenue, USD Million; 2020-2030) |
|
North America |
U.S. |
Canada |
|
Europe |
Germany |
U.K. |
|
France |
|
Spain |
|
Italy |
|
Rest of the Europe |
|
Asia Pacific |
India |
Japan |
|
China |
|
South Korea |
|
Australia |
|
Rest of Asia-Pacific |
|
Middle East & Africa |
UAE |
Saudi Arabia |
|
South Africa |
|
Rest of Middle East &
Africa |
|
Latin America |
Brazil |
Mexico |
|
Argentina |
|
Rest of Latin America |
Figure 2 Veterinary Pain Management Market: Regional Dynamics
North America is anticipated to maintain its
dominant position in the veterinary pain management market throughout the
forecast period. This growth can be attributed to factors such as the
increasing adoption of pets and the rising per capita expenditure on animal
healthcare in the region. The prevalence of various animal diseases and
injuries is also contributing significantly to the market's expansion.
According to the National Pet Owners Survey
conducted by the American Pet Products Association, approximately 72 million
Americans own dogs, 46 million own cats, 12 million own freshwater fish, 15.6
million own birds, 6 million own reptiles, 3.8 million own horses, and 2.7
million own saltwater fish. With the growing number of pet and livestock
owners, there is a heightened concern for the health and well-being of these
animals. In the previous year, the country spent approximately USD 30 billion on
veterinary care and services, as reported by the American Veterinary Medical
Association. This increased awareness and expenditure on animal health are
expected to drive significant market growth in North America during the
forecast period.
In the United States, the market is
experiencing growth due to partnerships, agreements, mergers, and acquisitions
between companies. Many companies are introducing new products to the market.
For example, Cronus Pharma Specialties received approval from the US FDA for
its Carprofen Chewable Tablets, which is a generic version of Rimadyl by
Zoetis. This nonsteroidal anti-inflammatory drug (NSAID) has been proven to
effectively relieve pain and inflammation associated with osteoarthritis in
dogs. It also aids in managing postoperative pain related to soft tissue and
orthopedic surgeries.
Asia Pacific is expected to exhibit lucrative
growth during the forecast period, primarily driven by the increasing trend of
pet adoption and the region's developing economy. Additionally, the rising
incidence of animal diseases has heightened the demand for procedures, further
propelling market expansion in the region.
Companies Considered And Profiled In This Market Study
The players operating in the market have
undertaken several strategies related to the market in the period 2020-2022.
some of the prominent players in the Veterinary Pain Management market include
·
Adisseo
·
Adm
·
Ashish Life Science
Pvt. Ltd.
·
Assisi Animal
Health
·
Avazzia
·
Basf Se
·
Bayer Ag
·
Boehringer
Ingelheim International Gmbh
·
Cargill
Incorporated
·
Century
Pharmaceuticals Ltd.
·
Ceva Santé Animale
·
Chanelle Pharma
·
Charoen Pokphand
Group
·
Dechra
Pharmaceuticals
·
Dsm
·
Dupont
·
Elanco Animal
Health Incorporated
·
Evonik Industries
Ag
·
Fidelis Animal
Health
·
Idexx Laboratories
·
Irm Enterprises
Pvt. Ltd.
·
Kemin Industries
Inc.
·
K-Laser Usa
·
Labindia Healthcare
Private Limited
·
Medtronic
·
Merck & Co.,
Inc.
·
Morvel Laboratories
Pvt. Ltd.
·
Multi Radiance
Medical
·
Norbrook
Laboratories Limited
·
Novusint
·
Nutreco
·
Ourofino Animal
Health
·
Richter Pharma Ag
·
Sequent Scientific
Limited
·
Sound Technologies
·
Sumitomo Chemical
·
Vetindia
Pharmaceuticals Ltd.
·
Vetoquinol
·
Virbac
·
Zoetis Inc.
·
Zuche
Pharmaceuticals Pvt. Ltd.
Global Veterinary Pain Management Market Report Scope
Historical data |
2020 - 2022 |
Base year for estimation |
2022 |
Forecast period |
2023 - 2030 |
Market size value in 2022 |
USD 1.98 Billion |
Revenue forecast in 2030 |
USD 3.30 Billion |
Growth Rate |
CAGR of 6.6% from 2023 to 2030 |
Quantitative units |
Revenue in USD Million/Billion & CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share,
competitive landscape, growth factors, and trends |
Segments covered |
Product Type, Application, Route Of Administration, End User, Animal
Type |
Key companies profiled |
Boehringer Ingelheim International Gmbh, Zoetis
Inc., Elanco Animal Health Incorporated |
Regional Scope |
North America, Europe, Asia Pacific, Middle East & Africa, Latin
America |
Country Scope |
U.S., Canada, Germany, U.K., France, Italy,
Spain, India, Japan, China, Australia, South Korea, Saudi Arabia, UAE, South
Africa, Brazil, Mexico, Argentina |
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working
days) with purchase. Addition or alteration to country, regional &
segment scope. |
Product Type Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Drug Type
o
NSAIDs
o
Opioids
o
Local Anesthetics
o
Alpha-2 Agonists
o
Disease-modifying
Osteoarthritis Agents
o
Others
·
Device Type
o
Laser Therepy
Device
o
Electromagnetic
Device
Application Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Postoperative
·
Cancer
·
Arthritis
·
Others
Route Of
Administration Outlook (Revenue, USD Million/Billion; 2020-2030)
·
Oral
·
Parenteral
·
Topical
Animal Type
Outlook (Revenue, USD Million/Billion; 2020-2030)
·
Companion Animal
o
Dog
o
Cat
o
Horse
o
Others
·
Livestock Animal
o
Cattle
o
Swine
o
Others
End User Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Veterinary
Hospitals
·
Veterinary Clinics
·
Pharmacies and Drug
Store
Regional Outlook (Revenue,
USD Million/Billion; 2020-2030)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Spain
o
Italy
o
Rest of the Europe
·
Asia Pacific
o
India
o
Japan
o
China
o
South Korea
o
Australia
o
Rest of
Asia-Pacific
·
Middle East &
Africa
o
UAE
o
Saudi Arabia
o
South Africa
o
Rest of Middle East
& Africa
·
Latin America
o
Brazil
o
Mexico
o
Argentina
o
Rest of Latin
America
Recent Developments In Veterinary Pain Management Market:
·
In 2021, Elanco
Animal Health, a global animal health company, announced the acquisition of
Kindred Biosciences, a biopharmaceutical company focused on developing
innovative veterinary therapeutics. The acquisition aimed to expand Elanco's
product portfolio and strengthen its position in the veterinary medicine
market.
·
In 2020,
Zoetis, one of the leading animal health companies, acquired Performance
Livestock Analytics, a data-driven livestock analytics company. This
partnership allowed Zoetis to enhance its digital technology capabilities and
provide livestock producers with advanced analytics and insights to improve
animal health and productivity.
·
In 2019,
Boehringer Ingelheim, a pharmaceutical company specializing in human and animal
health, announced the acquisition of various animal health assets from Sanofi.
This strategic acquisition included several veterinary products, expanding
Boehringer Ingelheim's presence in key markets and reinforcing its commitment
to animal health.
·
Virbac, a
global animal health company, entered into a partnership with Lonza, a leading
contract development and manufacturing organization, in 2019. The partnership
aimed to develop and manufacture sterile injectable formulations for companion
animals. This collaboration allowed Virbac to leverage Lonza's expertise in
sterile manufacturing and expand its product offerings in the veterinary
medicines market.
·
In 2018, IDEXX
Laboratories, a company specializing in veterinary diagnostics and software
solutions, acquired Abaxis, a manufacturer of point-of-care blood analysis
systems for veterinary healthcare. This acquisition strengthened IDEXX's
position in the veterinary diagnostics market and allowed them to offer a
comprehensive range of innovative diagnostic solutions.
Veterinary pain management plays a vital role
in safeguarding the well-being and quality of life of animals. With increased
awareness, advancements in pain assessment, and multimodal approaches, veterinarians
can effectively alleviate pain in animals and improve their overall health
outcomes. Government policies, including regulatory guidelines, animal welfare
legislation, research funding, and education initiatives, contribute to the
advancement of veterinary pain management, ensuring that animals receive
compassionate care and relief from pain.
Chapter
1. Introduction |
|
1.1. Market Definition |
|
1.2. Research Scope |
|
1.2.1. Markets Covered |
|
1.2.2. Years Considered for
Study |
|
Chapter
2. Executive Summary |
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030 |
|
2.2. Veterinary Pain Management Market
Share by Product Type, 2022 vs 2030 (USD Million) |
|
2.3. Veterinary Pain Management Market
Share by Application, 2022 vs 2030 (USD Million) |
|
2.4. Veterinary Pain Management Market Share by Route Of
Administration, 2022 vs 2030 (USD Million) |
|
2.5. Veterinary Pain Management Market
Share by Animal Type, 2022 vs 2030 (USD Million) |
|
2.6. Veterinary Pain Management Market
Share by End User, 2022 vs 2030 (USD Million) |
|
2.7. Veterinary Pain Management Market
Share by Region, 2022 vs 2030 (USD Million) |
|
Chapter
3. Key Insights |
|
Chapter
4. Veterinary Pain Management Market Segmentation & Impact Analysis |
|
4.1. Veterinary Pain Management Market
Indicators Analysis |
|
4.1.1. Market Drivers
Analysis |
|
4.1.1.1.
Growth in companion animal population |
|
4.1.1.2. Increasing consumption of
meat & milk |
|
4.1.1.3.
Growing prevalence of diseases |
|
4.1.2. Market Restraint
Analysis |
|
4.1.2.1. Rising pet
care costs |
|
4.1.2.2. Side
Effects Associated With Treatment and High Cost of Certain Products |
|
4.1.3. Market Opportunity
Analysis |
|
4.1.3.1. Increasing
popularity of non-conventional and non-pharmaceutical treatment techniques |
|
4.1.3.2. Untapped
emerging markets |
|
4.2. Regulatory Analysis |
|
4.2.1. North America |
|
4.2.1.1. U.S. |
|
4.2.1.2. Canada |
|
4.2.2. Europe |
|
4.2.3. Asia Pacific |
|
4.2.3.1. India |
|
4.2.3.2. Japan |
|
4.2.3.3. China |
|
4.3. Technological Insights |
|
4.4. COVID-19 Impact analysis on
Veterinary Pain Management Market |
|
4.5. Porter’s Five Forces Analysis |
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
4.5.2. Bargaining Power of
Suppliers |
|
4.5.3. Threat of New Entrants |
|
4.5.4. Threat of Substitute
Products |
|
4.5.5. Intensity of Competitive
Rivalry |
|
4.6. Competitive Metric Space Analysis |
|
Chapter
5. Veterinary Pain Management Market, By Product Type (Market Size and
Forecast by Value - USD Million, 2020 - 2030) |
|
5.1. Veterinary Pain Management Market,
By Product Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
5.1.1. Drug Type |
|
5.1.1.1.
Drug Type Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
5.1.1.2. Drug Type
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
5.1.1.3. NSAIDs |
|
5.1.1.3.1. NSAIDs
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
5.1.1.3.2. NSAIDs Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
5.1.1.4. Opioids |
|
5.1.1.4.1. Opioids Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
5.1.1.4.2. Opioids Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
5.1.1.5. Local Anesthetics |
|
5.1.1.5.1. Local Anesthetics Market Estimates and Forecast, 2020-2030
(USD Million) |
|
5.1.1.5.2. Local Anesthetics Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
5.1.1.6. Alpha-2 Agonists |
|
5.1.1.6.1. Alpha-2
Agonists Market Estimates and Forecast, 2020-2030 (USD Million) |
|
5.1.1.6.2. Alpha-2 Agonists Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
5.1.1.7. Disease-modifying Osteoarthritis Agents |
|
5.1.1.7.1. Disease-modifying Osteoarthritis Agents Market Estimates
and Forecast, By Region, 2015-2029 (USD Million) |
|
5.1.1.7.2. Disease-modifying
Osteoarthritis Agents Market Estimates and Forecast, By Region, 2015-2029
(USD Million) |
|
5.1.1.8. Others |
|
5.1.1.8.1. Others Market Estimates and Forecast, 2015-2029 (USD
Million) |
|
5.1.1.8.2. Others Market Estimates and Forecast, By Region, 2015-2029
(USD Million) |
|
5.1.2. Device Type |
|
5.1.2.1. Device
Type Market Estimates and Forecast,
2020-2030 (USD Million) |
|
5.1.2.2. Device
Type Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
5.1.2.3. Laser Therepy Device |
|
5.1.2.3.1. Laser Therepy Device Market Estimates and Forecast,
2020-2030 (USD Million) |
|
5.1.2.3.2. Laser Therepy Device Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
5.1.2.4. Electromagnetic Device |
|
5.1.2.4.1. Electromagnetic Device Market Estimates and Forecast,
2020-2030 (USD Million) |
|
5.1.2.4.2. Electromagnetic Device Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
Chapter
6. Veterinary Pain Management Market, By Application (Market Size and
Forecast by Value - USD Million, 2020 - 2030) |
|
6.1. Veterinary Pain Management Market,
By Application (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
6.1.1. Postoperative |
|
6.1.1.1. Postoperative Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
6.1.1.2. Postoperative Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
6.1.2. Cancer |
|
6.1.2.1. Cancer Market Estimates and Forecast,
2020-2030 (USD Million) |
|
6.1.2.2. Cancer Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
6.1.3. Arthritis |
|
6.1.3.1. Arthritis
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
6.1.3.2. Arthritis
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
6.1.4. Others |
|
6.1.4.1. Others
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
6.1.4.2. Others
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Chapter
7. Veterinary Pain Management Market, By Route Of Administration (Market
Size and Forecast by Value - USD Million, 2020 - 2030) |
|
7.1. Veterinary Pain Management Market,
By Route Of Administration (Market Size and Forecast by Value - USD Million,
2022 & 2030) |
|
7.1.1. Oral |
|
7.1.1.1. Oral Market Estimates and Forecast,
2020-2030 (USD Million) |
|
7.1.1.2. Oral Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
7.1.2. Parenteral |
|
7.1.2.1. Parenteral Market Estimates and Forecast,
2020-2030 (USD Million) |
|
7.1.2.2. Parenteral Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
|
7.1.3. Topical |
|
7.1.3.1. Topical
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
7.1.3.2. Topical
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Chapter
8. Veterinary Pain Management Market, By Animal Type (Market Size and
Forecast by Value - USD Million, 2020 - 2030) |
|
8.1. Veterinary Pain Management Market,
By Animal Type (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
8.1.1. Companion Animal |
|
8.1.1.1. Companion Animal Market Estimates and Forecast, 2020-2030
(USD Million) |
|
8.1.1.2. Companion Animal Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
8.1.1.3. Dog |
|
8.1.1.3.1. Dog Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
8.1.1.3.2. Dog Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.1.4. Cat |
|
8.1.1.4.1. Cat Market Estimates and Forecast, 2020-2030 (USD Million) |
|
8.1.1.4.2.
Cat Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.1.5. Horse |
|
8.1.1.5.1. Horse Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
8.1.1.5.2. Horse Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.1.6. Others |
|
8.1.1.6.1. Others Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
8.1.1.6.2. Others Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.2. Livestock Animal |
|
8.1.2.1. Livestock Animal Market Estimates and Forecast, 2020-2030
(USD Million) |
|
8.1.2.2. Livestock Animal Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
8.1.2.3. Cattle |
|
8.1.2.3.1. Cattle Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
8.1.2.3.2. Cattle Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.2.4. Swine |
|
8.1.2.4.1. Swine Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
8.1.2.4.2. Swine Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
8.1.2.5. Others |
|
8.1.2.5.1. Others Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
8.1.2.5.2. Others Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Chapter
9. Veterinary Pain Management Market, By End User (Market Size and
Forecast by Value - USD Million, 2020 - 2030) |
|
9.1. Veterinary Pain Management Market,
By End User (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
9.1.1. Veterinary Hospitals |
|
9.1.1.1. Veterinary Hospitals Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
9.1.1.2. Veterinary Hospitals Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
9.1.2. Veterinary Clinics |
|
9.1.2.1. Veterinary Clinics Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
9.1.2.2. Veterinary Clinics Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
9.1.3. Pharmacies and Drug
Store |
|
9.1.3.1. Pharmacies
and Drug Store Market Estimates and Forecast, 2020-2030 (USD Million) |
|
9.1.3.2. Pharmacies
and Drug Store Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Chapter
10. Veterinary Pain Management Market, By Region (Market Size and Forecast by
Value - USD Million, 2020 - 2030) |
|
10.1. Veterinary Pain Management
Market, By Region (Market Size and Forecast by Value - USD Million, 2022
& 2030) |
|
10.2. North America |
|
10.2.1. North America Veterinary
Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.2.2. North America
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.2.3. North America
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.2.4. North America
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.2.5. North America
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.2.6. North America
Veterinary Pain Management Market, By Country, 2020-2030 (USD Million) |
|
10.2.7. U.S. |
|
10.2.7.1. U.S.
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.2.7.2. U.S.
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.2.7.3. U.S. Veterinary Pain
Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.2.7.4. U.S.
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.2.7.5. U.S. Veterinary Pain
Management Market, By End User, 2020-2030 (USD Million) |
|
10.2.8. Canada |
|
10.2.8.1. Canada
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.2.8.2. Canada
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.2.8.3. Canada Veterinary
Pain Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.2.8.4. Canada
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.2.8.5. Canada Veterinary Pain
Management Market, By End User, 2020-2030 (USD Million) |
|
10.3. Europe |
|
10.3.1. Europe Veterinary Pain
Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.2. Europe Veterinary Pain
Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.3. Europe Veterinary Pain
Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.3.4. EuropeVeterinary Pain
Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.5. EuropeVeterinary Pain
Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.6. Europe Veterinary Pain
Management Market, By Country, 2020-2030 (USD Million) |
|
10.3.7. Germany |
|
10.3.7.1. Germany
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.7.2. Germany
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.7.3. Germany
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.3.7.4. Germany
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.7.5. Germany
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.8. U.K. |
|
10.3.8.1. U.K.
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.8.2. U.K.
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.8.3. U.K.
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.3.8.4. U.K.
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.8.5. U.K.
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.9. France |
|
10.3.9.1. France
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.9.2. France
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.9.3. France Veterinary
Pain Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.3.9.4. France
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.9.5. France
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.10. Spain |
|
10.3.10.1. Spain
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.10.2. Spain
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.10.3. Spain
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.3.10.4. Spain
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.10.5. Spain
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.11. Italy |
|
10.3.11.1. Italy
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.3.11.2. Italy
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.3.11.3. Italy
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.3.11.4. Italy
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.3.11.5. Italy
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.3.12. Rest of Europe |
|
10.3.12.1. Rest
of Europe Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.3.12.2. Rest
of Europe Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
|
10.3.12.3. Rest
of Europe Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.3.12.4. Rest
of Europe Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
|
10.3.12.5. Rest
of Europe Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.4. Asia Pacific |
|
10.4.1. Asia Pacific Veterinary
Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.4.2. Asia Pacific Veterinary
Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.4.3. Asia Pacific Veterinary
Pain Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.4.4. Asia Pacific Veterinary
Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.5. Asia Pacific Veterinary
Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.4.6. Asia Pacific Veterinary
Pain Management Market, By Country, 2020-2030 (USD Million) |
|
10.4.7. India |
|
10.4.7.1. India Veterinary
Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.4.7.2. India
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.4.7.3. India Veterinary Pain Management
Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.4.7.4. India
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.7.5. India
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.4.8. Japan |
|
10.4.8.1. Japan
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.4.8.2. Japan
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.4.8.3. Japan
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.4.8.4. Japan
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.8.5. Japan
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.4.9. China |
|
10.4.9.1. China
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.4.9.2. China
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.4.9.3. China
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.4.9.4. China
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.10.5. China
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.4.10. South Korea |
|
10.4.10.1. South
Korea Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.4.10.2. South
Korea Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
|
10.4.10.3. South
Korea Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.4.10.4. South
Korea Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.10.5. South
Korea Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.4.11. Australia |
|
10.4.11.1.
Australia Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.4.11.2.
Australia Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
|
10.4.11.3.
Australia Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.4.11.4.
Australia Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
|
10.5.11.5.
Australia Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.4.12. Rest of Asia Pacific |
|
10.4.12.1. Rest
of Asia Pacific Veterinary Pain Management Market, By Product Type, 2020-2030
(USD Million) |
|
10.4.12.2. Rest
of Asia Pacific Veterinary Pain Management Market, By Application, 2020-2030
(USD Million) |
|
10.4.12.3. Rest
of Asia Pacific Veterinary Pain Management Market, By Route Of
Administration, 2020-2030 (USD Million) |
|
10.4.12.4. Rest
of Asia Pacific Veterinary Pain Management Market, By Animal Type, 2020-2030
(USD Million) |
|
10.5.12.5. Rest
of Asia Pacific Veterinary Pain Management Market, By End User, 2020-2030
(USD Million) |
|
10.5. Middle East & Africa |
|
10.5.1. Middle East &
Africa Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.5.2. Middle East &
AfricaVeterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
|
10.5.3. Middle East &
Africa Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.5.4. Middle East &
Africa Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.5. Middle East &
Africa Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.5.6. Middle East &
Africa Veterinary Pain Management Market, By Country, 2020-2030 (USD Million) |
|
10.5.7. UAE |
|
10.5.7.1. UAE
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.5.7.2. UAE
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.5.7.3. UAE
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.5.7.4. UAE
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.5.7.5. UAE
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.5.8. Saudi Arabia |
|
10.5.8.1. Saudi
Arabia Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.5.8.2. Saudi
Arabia Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.5.8.3. Saudi
Arabia Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.5.8.4. Saudi
Arabia Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
|
10.5.8.5. Saudi
Arabia Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.5.9. South Africa |
|
10.5.9.1. South
Africa Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.5.9.2. South
Africa Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
|
10.5.9.3. South
Africa Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.5.9.4. South
Africa Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
|
10.5.9.5. South
Africa Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.5.10. Rest of Middle East &
Africa |
|
10.5.10.1. Rest
of Middle East & Africa Veterinary Pain Management Market, By Product
Type, 2020-2030 (USD Million) |
|
10.5.10.2. Rest
of Middle East & Africa Veterinary Pain Management Market, By Application,
2020-2030 (USD Million) |
|
10.5.10.3. Rest
of Middle East & Africa Veterinary Pain Management Market, By Route Of
Administration, 2020-2030 (USD Million) |
|
10.5.10.4. Rest
of Middle East & Africa Veterinary Pain Management Market, By Animal
Type, 2020-2030 (USD Million) |
|
10.5.10.5. Rest
of Middle East & Africa Veterinary Pain Management Market, By End User,
2020-2030 (USD Million) |
|
10.6. Latin America |
|
10.6.1. Latin America
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.6.2. Latin America
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.6.3. Latin America Veterinary
Pain Management Market, By Route Of Administration, 2020-2030 (USD Million) |
|
10.6.4. Latin America
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.6.5. Latin America
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.6.6. Latin America
Veterinary Pain Management Market, By Country, 2020-2030 (USD Million) |
|
10.6.7. Brazil |
|
10.6.7.1. Brazil
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.6.7.2. Brazil
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.6.7.3. Brazil
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.6.7.4. Brazil
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.6.7.5. Brazil
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.6.8. Mexico |
|
10.6.8.1. Mexico
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
|
10.6.8.2. Mexico
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.6.8.3. Mexico
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
|
10.6.8.4. Mexico
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
|
10.6.8.5. Mexico
Veterinary Pain Management Market, By End User, 2020-2030 (USD Million) |
|
10.6.9. Argentina |
|
10.6.9.1.
Argentina Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
|
10.6.9.2.
Argentina Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
|
10.6.9.3.
Argentina Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
|
10.6.9.4.
Argentina Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
|
10.6.9.5.
Argentina Veterinary Pain Management Market, By End User, 2020-2030 (USD
Million) |
|
10.6.10. Rest of Latin America |
|
10.6.10.1. Rest
of Latin America Veterinary Pain Management Market, By Product Type,
2020-2030 (USD Million) |
|
10.6.10.2. Rest
of Latin America Veterinary Pain Management Market, By Application, 2020-2030
(USD Million) |
|
10.6.10.3. Rest
of Latin America Veterinary Pain Management Market, By Route Of
Administration, 2020-2030 (USD Million) |
|
10.6.10.4. Rest
of Latin America Veterinary Pain Management Market, By Animal Type, 2020-2030
(USD Million) |
|
10.6.10.5. Rest
of Latin America Veterinary Pain Management Market, By End User, 2020-2030
(USD Million) |
|
Chapter
11. Competitive Landscape |
|
11.1. Market Revenue Share by
Manufacturers |
|
11.2. Competitor’s Positioning |
|
11.3. Strategy Benchmarking |
|
11.3.1. Partnership &
Agreement |
|
11.3.2. New Product
Development |
|
11.3.3. Mergers &
Acquisitions |
|
11.3.4. Investment &
Expansion |
|
11.4. Vendor Landscape |
|
11.4.1. Distributors |
|
11.4.2. North America |
|
11.4.3. Europe |
|
11.4.4. Asia Pacific |
|
11.4.5. Middle East &
Africa |
|
11.4.6. Latin America |
|
11.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
Chapter
12. Company Profiles |
|
12.1. Adisseo |
|
12.1.1. Company Overview |
|
12.1.2. Products Offered |
|
12.1.3. Financials |
|
12.1.4. Recent
Development |
|
12.2. Adm |
|
12.2.1. Company Overview |
|
12.2.2. Products Offered |
|
12.2.3. Financials |
|
12.2.4. Recent
Development |
|
12.3. Ashish Life Science Pvt. Ltd. |
|
12.3.1. Company Overview |
|
12.3.2. Products Offered |
|
12.3.3. Financials |
|
12.3.4. Recent
Development |
|
12.4. Assisi Animal Health |
|
12.4.1. Company Overview |
|
12.4.2. Products Offered |
|
12.4.3. Financials |
|
12.4.4. Recent
Development |
|
12.5. Avazzia |
|
12.5.1. Company Overview |
|
12.5.2. Products Offered |
|
12.5.3. Financials |
|
12.5.4. Recent
Development |
|
12.6. Basf Se |
|
12.6.1. Company Overview |
|
12.6.2. Products Offered |
|
12.6.3. Financials |
|
12.6.4. Recent
Development |
|
12.7. Bayer Ag |
|
12.7.1. Company Overview |
|
12.7.2. Products Offered |
|
12.7.3. Financials |
|
12.7.4. Recent
Development |
|
12.8. Boehringer Ingelheim International
Gmbh |
|
12.8.1. Company Overview |
|
12.8.2. Products Offered |
|
12.8.3. Financials |
|
12.8.4. Recent
Development |
|
12.9. Cargill Incorporated |
|
12.9.1. Company Overview |
|
12.9.2. Products Offered |
|
12.9.3. Financials |
|
12.9.4. Recent
Development |
|
12.10. Century Pharmaceuticals Ltd. |
|
12.10.1. Company Overview |
|
12.10.2. Products Offered |
|
12.10.3. Financials |
|
12.10.4. Recent
Development |
|
12.11. Ceva Santé Animale |
|
12.11.1. Company Overview |
|
12.11.2. Products Offered |
|
12.11.3. Financials |
|
12.11.4. Recent
Development |
|
12.12. Chanelle Pharma |
|
12.12.1. Company Overview |
|
12.12.2. Products Offered |
|
12.12.3. Financials |
|
12.12.4. Recent
Development |
|
12.13. Charoen Pokphand Group |
|
12.13.1. Company Overview |
|
12.13.2. Products Offered |
|
12.13.3. Financials |
|
12.13.4. Recent
Development |
|
12.14. Dechra Pharmaceuticals |
|
12.14.1. Company Overview |
|
12.14.2. Products Offered |
|
12.14.3. Financials |
|
12.14.4. Recent
Development |
|
12.15. Dsm |
|
12.15.1. Company Overview |
|
12.15.2. Products Offered |
|
12.15.3. Financials |
|
12.15.4. Recent
Development |
|
12.16. Dupont |
|
12.16.1. Company Overview |
|
12.16.2. Products Offered |
|
12.16.3. Financials |
|
12.16.4. Recent Development |
|
12.17. Elanco Animal Health Incorporated |
|
12.17.1. Company Overview |
|
12.17.2. Products Offered |
|
12.17.3. Financials |
|
12.17.4. Recent
Development |
|
12.18. Evonik Industries Ag |
|
12.18.1. Company Overview |
|
12.18.2. Products Offered |
|
12.18.3. Financials |
|
12.18.4. Recent
Development |
|
12.19. Fidelis Animal Health |
|
12.19.1. Company Overview |
|
12.19.2. Products Offered |
|
12.19.3. Financials |
|
12.19.4. Recent
Development |
|
12.20. Idexx Laboratories |
|
12.20.1. Company Overview |
|
12.20.2. Products Offered |
|
12.20.3. Financials |
|
12.20.4. Recent
Development |
|
12.21. Irm Enterprises Pvt. Ltd. |
|
12.21.1. Company Overview |
|
12.21.2. Products Offered |
|
12.21.3. Financials |
|
12.21.4. Recent
Development |
|
12.22. Kemin Industries Inc. |
|
12.22.1. Company Overview |
|
12.22.2. Products Offered |
|
12.22.3. Financials |
|
12.22.4. Recent
Development |
|
12.23. K-Laser Usa |
|
12.23.1. Company Overview |
|
12.23.2. Products Offered |
|
12.23.3. Financials |
|
12.23.4. Recent
Development |
|
12.24. Labindia Healthcare Private
Limited |
|
12.24.1. Company Overview |
|
12.24.2. Products Offered |
|
12.24.3. Financials |
|
12.24.4. Recent
Development |
|
12.25. Medtronic |
|
12.25.1. Company Overview |
|
12.25.2. Products Offered |
|
12.25.3. Financials |
|
12.25.4. Recent
Development |
|
12.26. Novusint |
|
12.26.1. Company Overview |
|
12.26.2. Products Offered |
|
12.26.3. Financials |
|
12.26.4. Recent
Development |
|
12.27. Morvel Laboratories Pvt. Ltd. |
|
12.27.1. Company Overview |
|
12.27.2. Products Offered |
|
12.27.3. Financials |
|
12.27.4. Recent
Development |
|
12.28. Multi Radiance Medical |
|
12.28.1. Company Overview |
|
12.28.2. Products Offered |
|
12.28.3. Financials |
|
12.28.4. Recent
Development |
|
12.29. Norbrook Laboratories Limited |
|
12.29.1. Company Overview |
|
12.29.2. Products Offered |
|
12.29.3. Financials |
|
12.29.4. Recent
Development |
|
12.30. Novusint |
|
12.30.1. Company Overview |
|
12.30.2. Products Offered |
|
12.30.3. Financials |
|
12.30.4. Recent Development |
|
12.31. Nutreco |
|
12.31.1. Company Overview |
|
12.31.2. Products Offered |
|
12.31.3. Financials |
|
12.31.4. Recent
Development |
|
12.32. Ourofino Animal Health |
|
12.32.1. Company Overview |
|
12.32.2. Products Offered |
|
12.32.3. Financials |
|
12.32.4. Recent
Development |
|
12.33. Richter Pharma Ag |
|
12.33.1. Company Overview |
|
12.33.2. Products Offered |
|
12.33.3. Financials |
|
12.33.4. Recent
Development |
|
12.34. Sequent Scientific Limited |
|
12.34.1. Company Overview |
|
12.34.2. Products Offered |
|
12.34.3. Financials |
|
12.34.4. Recent
Development |
|
12.35. Sound Technologies |
|
12.35.1. Company Overview |
|
12.35.2. Products Offered |
|
12.35.3. Financials |
|
12.35.4. Recent
Development |
|
12.36. Sumitomo Chemical |
|
12.36.1. Company Overview |
|
12.36.2. Products Offered |
|
12.36.3. Financials |
|
12.36.4. Recent
Development |
|
12.37. Vetindia Pharmaceuticals Ltd. |
|
12.37.1. Company Overview |
|
12.37.2. Products Offered |
|
12.37.3. Financials |
|
12.37.4. Recent
Development |
|
12.38. Vetoquinol |
|
12.38.1. Company Overview |
|
12.38.2. Products Offered |
|
12.38.3. Financials |
|
12.38.4. Recent
Development |
|
12.39. Virbac |
|
12.39.1. Company Overview |
|
12.39.2. Products Offered |
|
12.39.3. Financials |
|
12.39.4. Recent
Development |
|
12.40. Zoetis Inc. |
|
12.40.1. Company Overview |
|
12.40.2. Products Offered |
|
12.40.3. Financials |
|
12.40.4. Recent
Development |
|
12.41. Zuche Pharmaceuticals Pvt. Ltd. |
|
12.41.1. Company Overview |
|
12.41.2. Products Offered |
|
12.41.3. Financials |
|
12.41.4. Recent
Development |
|
Chapter
12. Research Methodology |
|
12.1. Research Sources |
|
12.1.1. Primary |
|
12.1.2. Secondary |
|
12.12. Market Size Estimation |
|
Chapter
13. Appendix |
|
13.1.
Discussion guide |
|
13.2.
Knowledge Store: Zettabyte Analytics Subscription Portal |
|
13.3. Available
Customizations |
|
13.4.
Associated Zettabyte Analytics Reports |
|
List of
Tables |
|
Table 1 |
Veterinary
Pain Management Market, By Product Type (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Table 2 |
Drug
Type Market Estimates and Forecast,
2020-2030 (USD Million) |
Table 3 |
Drug
Type Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
Table 4 |
Device
Type Market Estimates and Forecast,
2020-2030 (USD Million) |
Table 5 |
Device
Type Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
Table 6 |
Veterinary
Pain Management Market, By Application (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Table 7 |
Postoperative
Market Estimates and Forecast, 2020-2030 (USD Million) |
Table 8 |
Postoperative
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
Table 9 |
Veterinary
Pain Management Market, By Route Of Administration (Market Size and Forecast
by Value - USD Million, 2022 & 2030) |
Table 10 |
Oral
Market Estimates and Forecast, 2020-2030 (USD Million) |
Table 11 |
Oral
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
Table 12 |
Parenteral
Market Estimates and Forecast, 2020-2030 (USD Million) |
Table 13 |
Parenteral
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
Table 14 |
Topical
Market Estimates and Forecast, 2020-2030 (USD Million) |
Table 15 |
Topical
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
Table 16 |
Veterinary
Pain Management Market, By Animal Type (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Table 17 |
Companion
Animal Market Estimates and Forecast,
2020-2030 (USD Million) |
Table 18 |
Companion
Animal Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
Table 19 |
Livestock
Animal Market Estimates and Forecast,
2020-2030 (USD Million) |
Table 20 |
Livestock
Animal Market Estimates and Forecast,
By Region, 2020-2030 (USD Million) |
Table 21 |
North
America Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 22 |
North
America Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 23 |
North
America Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 24 |
North
America Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 25 |
North
America Veterinary Pain Management Market, By Country, 2020-2030 (USD
Million) |
Table 26 |
U.S.
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 27 |
U.S. Veterinary
Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 28 |
U.S.
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 29 |
U.S.
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 30 |
Canada
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 31 |
Canada
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 32 |
Canada
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 33 |
Canada
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 34 |
Europe
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 35 |
Europe Veterinary
Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 40 |
Europe
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 37 |
EuropeVeterinary
Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 38 |
Europe
Veterinary Pain Management Market, By Country, 2020-2030 (USD Million) |
Table 39 |
Germany
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 40 |
Germany
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 41 |
Germany
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 42 |
Germany
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 43 |
U.K. Veterinary
Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 44 |
U.K.
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 45 |
U.K.
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 46 |
U.K.
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 47 |
France
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 48 |
France
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 49 |
France
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 50 |
France
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 51 |
Spain
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 52 |
Spain
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 53 |
Spain
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 54 |
Spain
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 55 |
Italy
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 56 |
Italy
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 57 |
Italy
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 58 |
Italy
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 59 |
Rest of
Europe Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 60 |
Rest of
Europe Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 61 |
Rest of
Europe Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 62 |
Rest of
Europe Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 63 |
Asia
Pacific Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 64 |
Asia
Pacific Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 65 |
Asia
Pacific Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 66 |
Asia
Pacific Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 67 |
Asia
Pacific Veterinary Pain Management Market, By Country, 2020-2030 (USD
Million) |
Table 68 |
India
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 69 |
India
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 70 |
India
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 71 |
India
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 72 |
Japan
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 73 |
Japan
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 74 |
Japan
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 75 |
Japan
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 76 |
China
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 77 |
China
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 78 |
China
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 79 |
China
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 80 |
South
Korea Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 81 |
South
Korea Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 82 |
South
Korea Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 83 |
South
Korea Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 84 |
Australia
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 85 |
Australia
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 86 |
Australia
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 87 |
Australia
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 88 |
Rest of
Asia Pacific Veterinary Pain Management Market, By Product Type, 2020-2030
(USD Million) |
Table 89 |
Rest of
Asia Pacific Veterinary Pain Management Market, By Application, 2020-2030
(USD Million) |
Table 90 |
Rest of
Asia Pacific Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 91 |
Rest of
Asia Pacific Veterinary Pain Management Market, By Animal Type, 2020-2030
(USD Million) |
Table 92 |
Middle
East & Africa Veterinary Pain Management Market, By Product Type,
2020-2030 (USD Million) |
Table 93 |
Middle
East & AfricaVeterinary Pain Management Market, By Application, 2020-2030
(USD Million) |
Table 94 |
Middle
East & Africa Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 95 |
Middle
East & Africa Veterinary Pain Management Market, By Animal Type,
2020-2030 (USD Million) |
Table 96 |
Middle
East & Africa Veterinary Pain Management Market, By Country, 2020-2030
(USD Million) |
Table 97 |
UAE Veterinary
Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 98 |
UAE
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 99 |
UAE
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 100 |
UAE
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 101 |
Saudi
Arabia Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 102 |
Saudi
Arabia Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 103 |
Saudi
Arabia Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 104 |
Saudi
Arabia Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 105 |
South
Africa Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 106 |
South
Africa Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 107 |
South
Africa Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 108 |
South
Africa Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 109 |
Rest of
Middle East & Africa Veterinary Pain Management Market, By Product Type,
2020-2030 (USD Million) |
Table 110 |
Rest of
Middle East & Africa Veterinary Pain Management Market, By Application,
2020-2030 (USD Million) |
Table 111 |
Rest of
Middle East & Africa Veterinary Pain Management Market, By Route Of
Administration, 2020-2030 (USD Million) |
Table 112 |
Rest of
Middle East & Africa Veterinary Pain Management Market, By Animal Type,
2020-2030 (USD Million) |
Table 113 |
Latin
America Veterinary Pain Management Market, By Product Type, 2020-2030 (USD
Million) |
Table 114 |
Latin
America Veterinary Pain Management Market, By Application, 2020-2030 (USD
Million) |
Table 115 |
Latin
America Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 116 |
Latin
America Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD
Million) |
Table 117 |
Latin
America Veterinary Pain Management Market, By Country, 2020-2030 (USD
Million) |
Table 118 |
Brazil
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 119 |
Brazil Veterinary
Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 120 |
Brazil
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 121 |
Brazil
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 122 |
Mexico
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 123 |
Mexico
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 124 |
Mexico
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 125 |
Mexico
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 126 |
Argentina
Veterinary Pain Management Market, By Product Type, 2020-2030 (USD Million) |
Table 127 |
Argentina
Veterinary Pain Management Market, By Application, 2020-2030 (USD Million) |
Table 128 |
Argentina
Veterinary Pain Management Market, By Route Of Administration, 2020-2030 (USD
Million) |
Table 129 |
Argentina
Veterinary Pain Management Market, By Animal Type, 2020-2030 (USD Million) |
Table 130 |
Rest of
Latin America Veterinary Pain Management Market, By Product Type, 2020-2030
(USD Million) |
Table 131 |
Rest of
Latin America Veterinary Pain Management Market, By Application, 2020-2030
(USD Million) |
Table 132 |
Rest of
Latin America Veterinary Pain Management Market, By Route Of Administration,
2020-2030 (USD Million) |
Table 133 |
Rest of
Latin America Veterinary Pain Management Market, By Animal Type, 2020-2030
(USD Million) |
Table 134 |
Product
Launch & Development in The Veterinary Pain Management Market, 2018-2021 |
Table 135 |
Investment
and Expansion in The Veterinary Pain Management Market, 2020-2022 |
Table 140 |
Partnership
& Collaboration in The Veterinary Pain Management Market, 2020-2022 |
Table 137 |
Merger
& Acquisition in The Veterinary Pain Management Market, 2020-2022 |
List of
Figures |
|
Figure 1 |
Research
Methodology |
Figure 2 |
Summary
Snapshot Market Size and Forecast, USD Million, 2022 & 2030 |
Figure 3 |
Global
Veterinary Pain Management Market Segmentation & Impact Analysis |
Figure 4 |
Regulatory
Analysis |
Figure 5 |
COVID-19
Impact analysis on Veterinary Pain Management Market |
Figure 6 |
Market
Revenue Share by Manufacturers |
Figure 7 |
Veterinary
Pain Management Market, By Product Type (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Figure 8 |
Veterinary
Pain Management Market, By Application (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Figure 9 |
Veterinary
Pain Management Market, By Route Of Administration (Market Size and Forecast
by Value - USD Million, 2022 & 2030) |
Figure 10 |
Veterinary
Pain Management Market, By Animal Type (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
Figure 11 |
Veterinary
Pain Management Market, By Region (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States
Copyright © 2024 ZettaByte Analytics LLP All rights reserved.
Managed by TechnoGripper Solutions Private Limited